Humacyte Inc Warrant
HUMAW
9 hedge funds and large institutions have $333K invested in Humacyte Inc Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.06% less ownership
Funds ownership: 0.84% → 0.77% (-0.06%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
42% less capital invested
Capital invested by funds: $573K → $333K (-$240K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$3.67K |
| 2 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
+$3.22K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$18.5K |
| 2 |
ETH
Exos TFP Holdings
New York
|
-$12.6K |
| 3 |
Walleye Capital
New York
|
-$8.61K |
| 4 |
LPL Financial
San Diego,
California
|
-$6.57K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JAIC
1
Josh Arnold Investment Consultant
Edina,
Minnesota
| $108K | +$3.22K | +6,559 | +3% |
|
|
2
LPL Financial
San Diego,
California
| $104K | -$6.57K | -13,366 | -5% |
|
|
3
Walleye Capital
New York
| $45.3K | -$8.61K | -17,525 | -14% |
|
|
SCM
4
Sio Capital Management
New York
| $21.6K | – | – | – |
|
5
Jane Street
New York
| $20.8K | – | – | – |
|
|
LP
6
LMR Partners
London,
United Kingdom
| $20.5K | – | – | – |
|
|
CH
7
CVI Holdings
Wilmington,
Delaware
| $7.82K | -$18.5K | -37,614 | -67% |
|
|
WAM
8
Wolverine Asset Management
Chicago,
Illinois
| $3.44K | +$3.67K | +7,479 | +958% |
|
|
9
UBS Group
Zurich,
Switzerland
| $2.25K | +$2.65K | +5,403 | New |
|
|
ETH
10
Exos TFP Holdings
New York
| – | -$12.6K | -17,500 | Closed |
|
HUMAW Hedge Fund Activity: Q4 2023 in Review
9 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q4 2023, worth a combined $333K — down 42% from $573K a quarter earlier.
Fund positioning in HUMAW was balanced in Q4 2023: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $3.67K. The largest seller was CVI Holdings, cutting an estimated $18.5K.
- 9 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $333K of Humacyte Inc Warrant stock for Q4 2023, down 42% quarter-over-quarter.
- 1 fund opened new Humacyte Inc Warrant positions in Q4 2023 and 1 closed out, a net change of 0 holders.
- The largest Humacyte Inc Warrant buyer in Q4 2023 was Wolverine Asset Management, an estimated $3.67K added.
- The largest Humacyte Inc Warrant seller in Q4 2023 was CVI Holdings, an estimated $18.5K sold.
Based on aggregated 13F filings for Q4 2023.